CancerZoom.com?
Seen Robert Shapiro hawking LegalZoom.com? Well, according to the WSJ Health Blog on Thursday, soon the same kind of templates used to give you a quickie will or corporation could give you a cancer clinical trial.
Yes, clinical trials may soon be churned out template-style by some legal eagles, industry leaders, and corporate heads including AstraZeneca, Lilly, Pfizer, and Wyeth. Thanks to similar language used in between 75% to 80% of protocols now most trials can just be the same old language--but the real problem is that they are all the more likely to be rubber stamped.
Why wouldn't they? They contain the same basic language, the same ethics sections for IRB purposes, and differ only in regard to the technical details of their protocols, why wouldn't all these cancer clinical trials be all the more likely as their templates get more and more honed to sail through both scientific and ethics review? The answer is--they would.
Summer Johnson, PhD
contribute a comment
Your contributions to the conversation are very much appreciated. We do have a few simple guidelines, though. Be civil. Stay on topic. We reserve the right to remove comments that violate the aforementioned guidelines. One more thing: comments are moderated, so it may take a little while for your comment to be posted. Thanks.
comments
A very interesting idea. I am not sure if it will turn out more studies but it will help those developing studies to meet all of the requirements needed for regulatory approval.
- by PharmacistMike on Sep 22, 2008 at 8:21 AM | link